Eplerenone 50mg

DRUG2 trials

Sponsors

Tufts Medical Center, University of Michigan

Conditions

Central Serous ChorioretinopathyHypertension

Phase 2

Eplerenone for Central Serous Chorioretinopathy

CompletedNCT01822561

Tufts Medical CenterCentral Serous Chorioretinopathy

Start: 2013-05-31End: 2017-12-31Updated: 2018-05-16

Phase 4

Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA)

WithdrawnNCT04746495

University of MichiganHypertension

Start: 2023-02-28End: 2023-12-01Updated: 2023-02-21

Related Papers

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

International Journal of Retina and Vitreous2019-09-098 citations